Featured Bioprocessing Editorial
- 
                    When Single-Use Technology Becomes An Economic Imperative
                        9/3/2025
                    Industry changes increasingly favor SUT for novel products, even while stainless steel remains an essential part of many process trains. 
- 
                    Lilly's Exploring A Universal AAV Purification Method
                        9/2/2025
                    Serotype-specific resins don't scale gracefully. One team at Eli Lilly and Company is exploring an alternative that skips affinity resins altogether. 
- 
                    CSL Behring's Robotics Push Is One Of The Biggest We've Seen Yet
                        9/2/2025
                    An expansion project, including an abundance of automation features, at the CSL's Victoria, Australia, campus earned the company an ISPE Facility of the Year Award. 
- 
                    FDA Report Details FY24 Inspections, Shows Big Uptick In Key Countries
                        8/29/2025
                    The 2024 Report on the State of Pharmaceutical Quality shows the agency's efforts to normalize post-pandemic oversight under the previous administration. 
- 
                    Unpacking Pfizer's Advanced Process Control Platform For Upstream Ops
                        8/29/2025
                    Pfizer's advanced process control platform gives modelers more dexterity compared to default controllers, thus speeding up process development. 
- 
                    The OBBBA: Biopharmas Unlock R&D Expensing, Global Tax Efficiencies
                        8/28/2025
                    Biopharma innovators may soon see major tax breaks thanks to the One Big Beautiful Bill Act (OBBBA). The new legislation introduces targeted tax incentives designed to strengthen domestic R&D and capital investment. 
- 
                    New FDA White Paper Ties Quality To Financial Benefits
                        8/26/2025
                    The agency presents as a stepwise approach in which companies can make incremental investments rather than committing large amounts of capital upfront. 
- 
                    Calculating The Right In-House/Outsource Mix For ADC Manufacturing
                        8/21/2025
                    Antibody-drug conjugate innovators often question whether to outsource manufacturing activities or bring them in-house. Here are some key considerations. 
- 
                    Report: Nearly 40% Of Biomanufacturers Eyeing Continuous Processing
                        8/19/2025
                    Continuous perfusion manufacturing came about before the technology was mature enough to support it. Now, new data suggests an inflection point in the status quo. 
- 
                    Advancing CAR T Cell Therapy with Logic Gate Engineering
                        8/19/2025
                    Logic gating applies Boolean logic principles to CAR T cell design to improve precision and minimize collateral damage. 
